<i>ALC1</i> (IMAGE)
Caption
When PARP1 and NAD+ are on the scene, they alter the state of the chromatin-remodeling enzyme and suspected oncogene ALC1 from dormant to active.
Credit
Courtesy of Rushi Trivedi, Stowers Institute for Medical Research
Usage Restrictions
None
License
Licensed content